Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Leukocytes and Plasma of Children with Nonalcoholic Fatty Liver Disease

Table 1

Anthropometric and clinical characteristics of the study (NAFLD) and control groups.

	NAFLD	Control
No.	35	37
Age (years)
Height (cm)
Weight (kg)
BMI (kg/m^2)
SDS-BMI
ALT (IU/L)
AST (IU/L)
GGT (IU/L)
TG (mg/dL)
TC (mg/dL)
HDL-C (mg/dL)
LDL-C (mg/dL)
hs-CRP (mg/dL)
Waist circumference
Hip circumference
WHR	0.96	0.82
Fasting glucose (mg/dL)
Fasting insulin (μIU/mL)
HOMA-IR

ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyltransferase; TG: triglycerides; TC: total cholesterol; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low-density lipoprotein-cholesterol; hs-CRP: high-sensitivity C-reactive protein; WHR: waist to hip ratio; HOMA-IR: homeostasis model assessment of insulin resistance.